Alveus Therapeutics ApS
44689790ActiveClinical-stage biotech developing next-generation therapies for obesity and metabolic diseases.
Overview
- 10
- Employees
- Unknown
- Revenue
- 2024
- Founded
Description
Alveus Therapeutics is a clinical-stage biotechnology company focused on developing next-generation therapies for obesity and metabolic diseases. Headquartered in Philadelphia with R&D operations in Copenhagen, the company is backed by a $197 million Series A financing round. Their lead program,...
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK44689790
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrAntag Therapeutics ApS
8 employeesPioneering novel GIP receptor antagonist therapies for treating chronic obesity.
ScandiBio Therapeutics AB
0 employeesAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
SACRA Therapeutics AB
0 employeesSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Abarceo Pharma AB
5–9 employeesDeveloping novel small molecule therapeutics targeting VDAC1 for diabetes.
ICON Clinical Research Limited Ireland, filial
50–99 employeesGlobal clinical research organization providing outsourced development services.
Alveus Therapeutics ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo